Public Webinar: Patient-Focused Drug Development Draft Guidance 3
Рет қаралды 2,235
Күн бұрынOn September 9, 2022, the U.S. Food and Drug Administration (FDA) hosted a webinar for industry, patient groups, and other interested stakeholders to discuss and answer questions about the draft guidance: Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments : www.fda.gov/re...
For more information, visit www.fda.gov/dr...
U.S. Food and Drug Administration
Рет қаралды 1,6 М.
U.S. Food and Drug Administration
Рет қаралды 1,2 М.
U.S. Food and Drug Administration
Рет қаралды 736
U.S. Food and Drug Administration
Рет қаралды 498
U.S. Food and Drug Administration
Рет қаралды 440
U.S. Food and Drug Administration
Рет қаралды 671
U.S. Food and Drug Administration
Рет қаралды 319
U.S. Food and Drug Administration
Рет қаралды 658
U.S. Food and Drug Administration
Рет қаралды 1,4 М.
FDA D.I.S.C.O. Burst Edition: FDA approval of Bizengri (zenocutuzumab-zbco) for Treatment of adul...
U.S. Food and Drug Administration
Рет қаралды 318
U.S. Food and Drug Administration
Рет қаралды 435
U.S. Food and Drug Administration
Рет қаралды 1,2 М.